Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

T-Ray Science Reorganizes

Photonics.com
Aug 2010
VANCOUVER, British Columbia, Aug. 25, 2010 — Medical device company T-Ray Science Inc. announced it has adopted a plan of reorganization to consolidate management and administration, resulting in a net savings of approximately $500,000 in cash expenditures over the next 12 months.

The reorganization will result in net savings from cash expenditures on general and administrative expenses, as well as the cancellation of 590,625 unvested options.

In addition, the role of the chief financial officer will be consolidated with the vice president of administration, which will be fulfilled by Anna Trinh, the current VP of administration. Thomas Braun, the current CEO, will step in as chief business development officer. The VP of product development position will be outsourced to consultants as needed.

T-Ray has also accepted the resignation of Ralph Braun, a member of the board of directors.

In connection with the consolidation, the company has granted 125,000 stock options at an exercise price of $0.25 per share, and 125,000 stock options at an exercise price of $0.30 per share to Trinh. With a five-year term, the options have vesting restrictions.

In addition, there are 6,617,469 shares reserved for issuance under the company’s stock option plan, and approximately 2,240,625 options currently outstanding.

For more information, visit: www.t-rayscience.com 


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.